Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000156525 | SCV000206244 | uncertain significance | not specified | 2014-04-16 | criteria provided, single submitter | clinical testing | The Pro318His variant in DTNA has not been previously reported in individuals wi th cardiomyopathy or in large population studies. Computational prediction tool s and conservation analysis suggest that the Pro318His variant may impact the pr otein, though this information is not predictive enough to determine pathogenici ty. In summary, the clinical significance of the Pro318His variant is uncertain. |
New York Genome Center | RCV003335138 | SCV004046526 | uncertain significance | Left ventricular noncompaction 1 | 2023-02-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000156525 | SCV005119381 | uncertain significance | not specified | 2024-05-28 | criteria provided, single submitter | clinical testing | The c.953C>A (p.P318H) alteration is located in exon 9 (coding exon 8) of the DTNA gene. This alteration results from a C to A substitution at nucleotide position 953, causing the proline (P) at amino acid position 318 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |